Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alpine Immune Sciences Inc. (ALPN)

4.74   0.92 (24.08%) 08-16 15:59
Open: 3.9 Pre. Close: 3.82
High: 4.9473 Low: 3.84
Volume: 60,873 Market Cap: 88M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.956 - 4.975 4.975 - 4.994
Low: 3.8 - 3.818 3.818 - 3.837
Close: 4.704 - 4.738 4.738 - 4.772

Technical analysis

as of: 2019-08-16 4:45:50 PM
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.25     One year: 7.30
Support: Support1: 4.15    Support2: 3.41
Resistance: Resistance1: 5.35    Resistance2: 6.25
Pivot: 3.91
Moving Average: MA(5): 3.82     MA(20): 4.05
MA(100): 5.26     MA(250): 5.52
MACD: MACD(12,26): -0.14     Signal(9): -0.19
Stochastic oscillator: %K(14,3): 41.49     %D(3): 20.90
RSI: RSI(14): 62.62
52-week: High: 8.24  Low: 3.41  Change(%): -18.0
Average Vol(K): 3-Month: 1049  10-Days: 1379

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALPN has closed above the upper band by 4.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 29.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Aug 2019 17:13:49 Z
Analysts Estimate Alpine Immune Sciences (ALPN) to Report a Decline in Earnings: What to Look Out for

Mon, 06 May 2019 16:14:19 Z
Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline

Thu, 11 Apr 2019 17:09:12 Z
The Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion Energy

Fri, 05 Apr 2019 13:08:52 Z
Will Nivalis Therapeutics Continue to Surge Higher?

Thu, 04 Apr 2019 16:09:14 Z
The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 13.85
Shares Float (M) 3.86
% Held by Insiders 39.78
% Held by Institutions 46.54
Shares Short (K) 25
Shares Short P. Month (K)

Stock Financials

EPS -2.942
EPS Est. Current Year -3.180
EPS Est. Next Year -2.500
EPS Est. Next Quarter -1.030
Forward EPS -2.604
Book Value (p.s.) 3.050
PEG Ratio
Profit Margin
Operating Margin -11214.61
Return on Assets (ttm) -37.0
Return on Equity (ttm) -66.8
Qtrly Rev. Growth
Gross Profit (p.s.) -2.041
Sales Per Share
EBITDA (p.s.) -3.113
Qtrly Earnings Growth
Operating Cash Flow (M) -35.21
Levered Free Cash Flow (M) -19.52

Stock Valuations

P/E -1.61
P/E Growth Ratio 0.24
P/BV 1.55
P/S 2188300032.00
P/CF -1.86

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-07-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.